May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Involvement of Matrix Metalloproteinas–2 in corneal angiogenesis
Author Affiliations & Notes
  • B. Samolov
    St Eriks Eye Hospital, Karolinska Institutet, Stockholm, Sweden
  • B. Steen
    St Eriks Eye Hospital, Karolinska Institutet, Stockholm, Sweden
  • P. Montan
    St Eriks Eye Hospital, Karolinska Institutet, Stockholm, Sweden
  • A. Kvanta
    St Eriks Eye Hospital, Karolinska Institutet, Stockholm, Sweden
  • Footnotes
    Commercial Relationships  B. Samolov, None; B. Steen, None; P. Montan, None; A. Kvanta, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Samolov, B. Steen, P. Montan, A. Kvanta; Involvement of Matrix Metalloproteinas–2 in corneal angiogenesis . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4820.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Previous studies have demonstrated the importance of MMP–2 in choroidal (subretinal) neovascularisation. We set out to investigate the role of MMP–2 in corneal neovascularization. Methods:An inflammatory mouse model of corneal angiogenesis was used. A silk suture was placed in the centre of the cornea of homozygote wild–type (MMP–2 WT) and MMP–2 deficient mice (MMP–2 KO) to create a limbal ingrowth of vessels. Sutured animals were perfused with fluorescein dextran at 3, 6 and 9 days and the corneas were dissected and flat–mounted on glass slides. The neovascular area was quantified with digital image analysis. Expression of MMP–2 mRNA in the corneal angiogenesis model was done by in situ hybridization. Results:MMP–2 mRNA was strongly up–regulated in neovascularized corneas. Corneal neovascularisation in MMP–2 KO mice was decreased compared to MMP–2 WT mice. This difference was significant (p<0.01) at later time–points. Conclusions:In this mouse model MMP–2 seems to be involved in the development of the corneal neovascularisation. These results may have clinical applications through the existence of synthetic MMP–antagonsists.

Keywords: neovascularization • enzymes/enzyme inhibitors • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×